FundingNov 17, 2026 · 19:215 sources
Isomorphic Labs Raises $5B in Series C to Accelerate AI Drug Discovery
From marketbrief.now
Alphabet's AI drug-discovery company Isomorphic Labs raised $5 billion in a Series C round co-led by Sequoia Capital and Greenoaks. New investor Andreessen Horowitz joined the round, which also included existing backers Thrive Capital, GV and CapitalG. CEO Demis Hassabis said the capital will accelerate the company's progress toward human clinical trials, supporting more than 20 drug-development programs for cancer, inflammation and immune disorders.
The investment follows a $2.1 billion raise in May, totaling $7.1 billion in funding over the last six months. While Isomorphic works with partners including Eli Lilly, Novartis and Johnson & Johnson, no AI-designed drug has yet received regulatory approval and the company has not provided a specific timeline for its first clinical trials.
Sources
+ 1 more
- SUPPORT@wallstengine“funding comes just six months after Isomorphic raised $2.1 billion in May, bringing the combined amount raised across the two rounds to $7.1 billion”x.com
Content history (2)
- 2026-11-17 · Summary · vi · Replaced stored textIsomorphic Labs đã huy động được 5 tỷ USD trong vòng gọi vốn Series C nhằm đẩy nhanh tiến…Isomorphic Labs, công ty tìm kiếm thuốc bằng AI của Alphabet, đã huy động được 5 tỷ USD t…
- 2026-11-17 · Title · vi · Replaced stored textIsomorphic Labs huy động 5 tỷ USD trong vòng Series C để đẩy nhanh quá trình khám phá thu…Isomorphic Labs huy động 5 tỷ USD trong vòng Series C để đẩy nhanh quá trình tìm kiếm thu…
One ranked edition, every morning
The stories that matter today. Free, cancel anytime.
Telegram @aidr_today